Accuray | ARAY - Operating Profit


Accuray reported $4.71M in Operating Profit for its fiscal quarter ending in December of 2024.





Operating Profit Change Date
Abbott USD 2.25B 73M Dec/2025
Accuray USD 4.71M 6.86M Dec/2024
AngioDynamics USD -2.51M 5.41M Sep/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 2.49M 2.28M Dec/2025
Boston Scientific USD 1.24B 203M Dec/2025
Edwards Lifesciences USD 370.3M 54.8M Dec/2025
Hologic USD 237M 16M Dec/2025
Inogen USD -7.79M 728K Sep/2024
Mesa Laboratories USD 5.78M 2.27M Dec/2024
Orthofix International USD 6.12M 1.91M Dec/2025
Surmodics USD 58K 5.7M Jun/2025
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Trinity Biotech USD -509K 6.27M Sep/2025